
Adam C. Milligan
Examiner (ID: 12356, Phone: (571)270-7674 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 1623 |
| Total Applications | 584 |
| Issued Applications | 144 |
| Pending Applications | 6 |
| Abandoned Applications | 437 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8976147
[patent_doc_number] => 20130209577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Buffered Upper GI Absorption Promoter'
[patent_app_type] => utility
[patent_app_number] => 13/625652
[patent_app_country] => US
[patent_app_date] => 2012-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625652
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/625652 | Buffered Upper GI Absorption Promoter | Sep 23, 2012 | Abandoned |
Array
(
[id] => 9004522
[patent_doc_number] => 20130225647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'COMBINATION THERAPY WITH PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/624022
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 15383
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/624022 | COMBINATION THERAPY WITH PARP INHIBITORS | Sep 20, 2012 | Abandoned |
Array
(
[id] => 8708597
[patent_doc_number] => 20130065885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/618728
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14281
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13618728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/618728 | ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8841075
[patent_doc_number] => 20130136703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'LIMITED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 13/602093
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3856
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602093
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/602093 | Limited release lingual thioctic acid delivery systems | Aug 30, 2012 | Issued |
Array
(
[id] => 8862793
[patent_doc_number] => 20130146496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'SOLID PHARMACEUTICAL FORMULATIONS OF RAMIPRIL AND AMLODIPINE BESYLATE, AND THEIR PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/592958
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5599
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/592958 | SOLID PHARMACEUTICAL FORMULATIONS OF RAMIPRIL AND AMLODIPINE BESYLATE, AND THEIR PREPARATION | Aug 22, 2012 | Abandoned |
Array
(
[id] => 11914782
[patent_doc_number] => 09782957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Medical device films'
[patent_app_type] => utility
[patent_app_number] => 13/589222
[patent_app_country] => US
[patent_app_date] => 2012-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 5957
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13589222
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/589222 | Medical device films | Aug 19, 2012 | Issued |
Array
(
[id] => 8707599
[patent_doc_number] => 20130064888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'PHARMACEUTICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/569452
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7202
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13569452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/569452 | PHARMACEUTICAL FORMULATIONS | Aug 7, 2012 | Abandoned |
Array
(
[id] => 8495532
[patent_doc_number] => 20120294940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'RAPIDLY DISINTEGRATING TABLET IN ORAL CAVITY'
[patent_app_type] => utility
[patent_app_number] => 13/566160
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10494
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566160
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/566160 | RAPIDLY DISINTEGRATING TABLET IN ORAL CAVITY | Aug 2, 2012 | Abandoned |
Array
(
[id] => 9069837
[patent_doc_number] => 20130261593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'Device, System, and Method for Delivery of Sugar Glass Stabilized Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/554072
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20870
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13554072
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/554072 | Device, System, and Method for Delivery of Sugar Glass Stabilized Compositions | Jul 19, 2012 | Abandoned |
Array
(
[id] => 9630992
[patent_doc_number] => 20140209100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'INTRAVAGINAL DEVICES FOR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/233692
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14813
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233692
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233692 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Jul 19, 2012 | Abandoned |
Array
(
[id] => 17798975
[patent_doc_number] => 11413239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Pharmaceutical composition of tapentadol for nasal administration
[patent_app_type] => utility
[patent_app_number] => 14/233265
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7931
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233265 | Pharmaceutical composition of tapentadol for nasal administration | Jul 18, 2012 | Issued |
Array
(
[id] => 9490681
[patent_doc_number] => 20140141087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Oral Composition Comprising An Antacid, an Anaesthetic and an Inorganic Matrix Comprising Silicon Dioxide and Titanium Dioxide'
[patent_app_type] => utility
[patent_app_number] => 14/127682
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3665
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127682 | Oral Composition Comprising An Antacid, an Anaesthetic and an Inorganic Matrix Comprising Silicon Dioxide and Titanium Dioxide | Jul 12, 2012 | Abandoned |
Array
(
[id] => 9490578
[patent_doc_number] => 20140140985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 14/130020
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5949
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130020 | FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS | Jun 27, 2012 | Abandoned |
Array
(
[id] => 8453850
[patent_doc_number] => 20120264795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'COMBINATION THERAPY WITH PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/530232
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13674
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530232 | COMBINATION THERAPY WITH PARP INHIBITORS | Jun 21, 2012 | Abandoned |
Array
(
[id] => 8523410
[patent_doc_number] => 20120322818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'PHYCOTOXINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/526868
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11817
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526868 | Phycotoxins and uses thereof | Jun 18, 2012 | Issued |
Array
(
[id] => 9476782
[patent_doc_number] => 20140134245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'IBUPROFEN CHEWABLE TABLET'
[patent_app_type] => utility
[patent_app_number] => 14/126882
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126882
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126882 | IBUPROFEN CHEWABLE TABLET | Jun 17, 2012 | Abandoned |
Array
(
[id] => 8708596
[patent_doc_number] => 20130065886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/495942
[patent_app_country] => US
[patent_app_date] => 2012-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31361
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13495942
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/495942 | Administration of benzodiazepine compositions | Jun 12, 2012 | Issued |
Array
(
[id] => 13885245
[patent_doc_number] => 10195154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Method for producing orodispersible tablets
[patent_app_type] => utility
[patent_app_number] => 14/125240
[patent_app_country] => US
[patent_app_date] => 2012-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5690
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125240
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125240 | Method for producing orodispersible tablets | Jun 7, 2012 | Issued |
Array
(
[id] => 10932153
[patent_doc_number] => 20140335174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'DRY-COATED TABLET CONTAINING TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM'
[patent_app_type] => utility
[patent_app_number] => 14/118952
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7787
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118952
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118952 | DRY-COATED TABLET CONTAINING TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM | May 23, 2012 | Abandoned |
Array
(
[id] => 9868867
[patent_doc_number] => 08956635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Insect repellent devices'
[patent_app_type] => utility
[patent_app_number] => 13/477502
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 9695
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477502
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477502 | Insect repellent devices | May 21, 2012 | Issued |